PENILAIAN HARGA WAJAR SAHAM PT.KIMIA FARMA (PERSERO) Tbk DAN PT. INDOFARMA (PERSERO) Tbk MENJELANG AKUISISI
Abstract
Abstract: Regrouping pharmaceutical companies in Indonesia among PT. Kimia Farma(Persero) Tbk and PT. Indofarma (Persero) Tbk will be carried out by the government
through inbreng scheme. In order to take acquisitions, a fair price must be counted for,
so the public interests not be harmed For the fair price ofshares, the calculating are
using three (3) of valuation methods thats are freecash flowto equity, relative valuation
methods and gordon growth models. After doing the calculations with those methods,
affair price for the shares of PT. Kimia Farma (Persero) Tbkand PT. Indofarma
(Persero) Tbk its obtained. To get affair price to the value of the reference shares,
reconciliation should be done. Based onthe results of there conciliation, the fair prices
for thes hares of PT. Kimia Farma (Persero) Tbk is 693 rupiahs and PT. Indofarma
(Persero) Tbk iis 404 rupiahs with avalue range of 7.5 per centofthe fair price.
Keywords: Acquisitions, freecash flowto equity, relativevaluation, Gordon growth
models
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
The copyright to this article is transferred to Universitas Mercu Buana (UMB) if and when the article is accepted for publication. The undersigned hereby transfers any and all rights in and to the paper including without limitation all copyrights to UMB. The undersigned hereby represents and warrants that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required. The undersigned represents that he/she has the power and authority to make and execute this assignment.
We declare that this paper has not been published in the same form elsewhere.
Furthermore, I/We hereby transfer the unlimited rights of publication of the above mentioned paper in whole to UMB. The copyright transfer covers the right to reproduce and distribute the article, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or any other reproductions of similar nature.
The corresponding author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. This agreement is to be signed by at least one of the authors who have obtained the assent of the co-author(s) where applicable. After submission of this agreement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted.
Retained Rights/Terms and Conditions
Although authors are permitted to re-use all or portions of the Work in other works, this does not include granting third-party requests for reprinting, republishing, or other types of re-use.
